CClinicalTrials.gg
WithdrawnNCT03425851Updated Apr 12, 2018

Diaper Distribution in Low-Income Infants

An interventional study of Diapers and Resources of diaper banks in Diaper Rash, UTI and Depressive Symptoms, sponsored by Boston Medical Center. Withdrawn at 1 site in United States. Open to participants aged 2 Days to 9 Months. Per ClinicalTrials.gov, last updated 2018-04-12.

Sponsored by Boston Medical Center · Not applicable, Interventional, and Prevention

Why this study was withdrawn
Administrative issues precluded conducting the study.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
2 Days to 9 Months
Sex
All
01

Study summary

The adverse effects of poverty at the individual, family, and community level on health outcomes for children are well-established. Material hardship, defined as difficulty meeting basic needs such as food, housing, and consumer goods, has been shown to have negative physical and emotional effects on both children and their parents. Diaper need, defined as a lack of sufficient supply of clean and dry diapers, is an example of a material hardship.

Community-based studies of low-income families have demonstrated that between 30-50% of caregivers of young children expressed diaper need. Some of these caregivers with diaper need reported reducing diaper changes, a practice that is associated with diaper dermatitis and urinary tract infections (UTIs). These community-based studies have also shown that diaper need is associated with maternal depression and parental stress, even after adjusting for demographic factors and food insecurity. Diaper need may be a specific modifiable marker of caregiver stress and depression, beyond its role as an indicator of poverty. In this pilot, randomized controlled trial of low-income newborns and their caregivers the investigators will test the feasibility of supplying diapers as an intervention to infants in low-income families and assess if it can improve both a child's health and their caregiver's overall health.

Read the detailed description

Infants born at Boston Medical Center and their caregivers will be recruited at any scheduled visit at Boston Medical Center's primary care clinic between birth and 2 months of age. Eligible caregivers will complete a baseline survey and provide consent for the study investigators to perform a prospective chart review. The infant-caregiver pair will be randomized to the intervention group or the control group. The intervention group will receive 600 diapers, distributed in packs of 200 to the families at the conclusion of the 2 month, 4 month, and 6 month old well-child visits. The control group will receive resources of diaper banks in the greater Boston area.

Surveys:

  • Baseline: At the initial visit, the survey will obtain baseline data from the child's caregiver on prior history of diaper need, current employment and income, government benefits, and other material hardships. The survey will also include the Protective Factors Strength Level and Patient Health Questionnaire (PHQ-9), both validated measures. The survey will take approximately 15-20 minutes to complete. Baseline surveys will be completed in person.
  • Follow-up: At the 2 month, 4 month, 6 month, and 9 month well-child visits (as applicable based on age of enrollment), all enrolled families will complete a survey repeating the measures of diaper need, the Protective Factors Strength Level, and PHQ-9. Additional questions will ask about episodes of diaper rashes and economic impact of diaper need. Families in the intervention group will be asked about acceptability of the intervention at the conclusion of the study.

Chart review: After the completion of the 2 month, 4 month, 6 month, and 9 month well-child visits, study staff will review the medical record for attendance at planned well-child visits, adherence to the immunization schedule, number of urgent care and ED visits, and incidence of diaper dermatitis and urinary tract infections requiring treatment. Demographic information extracted will include sex, race/ethnicity, and confirmation of insurance status.

All survey and chart review data will be de-identified and entered into REDCap with a unique study identification number.

02

Conditions studied

  • Diaper Rash
  • UTI
  • Depressive Symptoms
  • Stress

Keywords

  • Diaper need
  • Infants
  • Well baby visits
  • Low-income families
  • Caregiver stress
03

Who can participate

Ages eligible
2 Days to 9 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Infants born at Boston Medical Center and seen in BMC pediatric primary care clinic at any outpatient visit between birth and 2 months of age.
  • Caregivers of enrolled infants, including parents and legal guardians.
  • Plan to obtain pediatric primary care at BMC for nine months.
  • Have public insurance or Medicaid as their primary source of health insurance.

Exclusion criteria

Exclusion Criteria:

  • Caregivers who are minors (under age 18).
  • Infants in the foster care system.
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Intervention Group

    Receive 600 diapers.

    Other: Diapers

  • Active comparator
    Control Group

    Receive resources of diaper banks as requested.

    Other: Resources of diaper banks

Interventions

  • OtherDiapers

    Receive 600 diapers.

  • OtherResources of diaper banks

    Caregivers will receive resources of diaper banks.

05

What researchers measure

Primary outcomes

  1. Caregiver acceptability of receiving diapers

    Qualitative interviews with caregivers to assess acceptability of intervention delivery from a clinic setting.

    Time frame: 9 months

  2. Rate of enrollment by eligible families

    Proportion of caregivers enrolled and proportion of caregivers declined enrollment out of total number of eligible families approached.

    Time frame: 9 months

  3. Rate of declination of enrollment by eligible families

    Proportion of caregivers declined enrollment out of total number of eligible families approached.

    Time frame: 9 months

Secondary outcomes

  1. Incidence of diaper dermatitis

    Episodes of diaper dermatitis diagnosed by clinicians at Boston Medical Center during a well-child, urgent care, or emergency department visit.

    Time frame: 9 months

  2. Incidence of UTIs

    Episodes of urinary tract infections diagnosed by urine culture during a well-child, urgent care, or emergency department visit at Boston Medical Center.

    Time frame: 9 months

  3. Attendance at planned well-child visits

    Proportion of attended well-child visits; expected to have 4-5 visits over 9 months based on age of enrollment

    Time frame: 9 months

  4. Adherence to the immunization schedule

    Received all required vaccines through 6 months of age according to the published CDC schedule by 7 months of age.

    Time frame: 9 months

  5. Change in caregiver well-being indices

    The Parents' Assessment of Protective Factors Instrument is used to measure the presence and magnitude of self-reported beliefs and behaviors that are indicators of the Strengthening Families protective factors, which can be used to mitigate risk factors and actively enhance family well-being. The instrument contains 36 items with a total score (Protective Factors Strength Index) and subscale scores for parental resilience, social connections, concrete support in times of need, social emotional competence of children. PFSI scores and subscales can range from 0 to 4, higher scores are more favorable. The change in PFSI scores compared to baseline score and immediately prior score at each time point will be measured.

    Time frame: baseline, 2 months, 4 months, 6 months, and 9 months

  6. Change in depressive symptoms of caregivers

    Patient Health Questionnaire (PHQ 9) is a multipurpose instrument for screening, measuring, and monitoring depressive symptoms. It contains 9 questions with response options referenced to the past 2 weeks from 0 to 3 where 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Scores can range form 0 to 27, lower scores are more favorable. The change in PHQ 9 scores compared to baseline score and immediately prior score at each time point will be measured.

    Time frame: baseline, 2 months, 4 months, 6 months, and 9 months

Other outcomes

  1. Survey completion time

    Average time in minutes to complete surveys

    Time frame: 9 months

06

Study locations

1 site
  • Boston Medical Center
    Boston, Massachusetts 02118, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03425851
Lead sponsor
Boston Medical Center
Collaborators
Health Resources and Services Administration (HRSA)
Responsible party
Hong-An Nguyen (Fellow, Dept of Pediatrics, Boston Medical Center) — Principal investigator
First posted
Feb 8, 2018
Start date
Mar 14, 2018
Primary completion
Jan 2019 (estimated)
Completion
Jan 2019 (estimated)
Last update
Apr 12, 2018

Study contacts

Hong-An Nguyen, MD
principal investigator · Boston Medical Center
Caroline Kistin, MD
principal investigator · Boston Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion